Mechanisms of Tumor Induction by Peroxisome Proliferators
- 1 January 1988
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and manPharmacology & Therapeutics, 1985
- Characterization of liver enlargement induced by compound LY171883 in ratsFundamental and Applied Toxicology, 1985
- Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalateCarcinogenesis: Integrative Cancer Research, 1985
- Lack of covalent binding of peroxisome proliferators nafenopin and WY-14 643 to DNA in vivo and in vitroToxicology Letters, 1984
- Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferative lesions after short-term exposure in male B6C3F1 miceCancer Letters, 1984
- Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents Clofibrate and Nafenopin on the rat liver cell membrane enzymes γ-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesisCarcinogenesis: Integrative Cancer Research, 1984
- Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytesCarcinogenesis: Integrative Cancer Research, 1984
- Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liverCarcinogenesis: Integrative Cancer Research, 1984
- The absence of γglutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643Carcinogenesis: Integrative Cancer Research, 1982
- Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrateToxicology Letters, 1981